Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Katalin Váradi
Observed names:
K Varadi,
K Váradi,
K. VARADI,
K. Varadi,
K. Váradi,
Katalin Varadi,
Katalin Váradi,
Katalin Vàradi,
Varadi, K.
show all 9
Institution:
Baxter (Austria)
Observed institutions:
University of Vienna,
University of Debrecen,
Sanquin,
Hungarian National Blood Transfusion Service,
Baxter (Austria),
Hôpital Lariboisière,
Hôpital Raymond-Poincaré,
Baxter (United States)
show all 8
OpenAlex ID:
A5002259817
Effects of Protein S and Factor Xa on Peptide Bond Cleavages during Inactivation of Factor Va and Factor VaR506Q by Activated Protein C
1995
·
Jan Rosing
, Lico Hoekema
, et al.
·
Journal of Biological Chemistry
·
255
Peptide Bond Cleavages and Loss of Functional Activity during Inactivation of Factor Va and Factor VaR506Q by Activated Protein C
1995
·
Gerry A.F. Nicolaes
, Guido Tans
, et al.
·
Journal of Biological Chemistry
·
253
FEIBA®: mode of action
2004
·
P. L. Turecek
, K. Váradi
, et al.
·
Haemophilia
·
182
Monitoring the bioavailability of FEIBA with a thrombin generation assay
2003
·
K. Váradi
, C. Negrier
, et al.
·
Journal of Thrombosis and Haemostasis
·
152
PDF
Changes in ADAMTS13 (von-Willebrand-factor-cleaving protease) activity after induced release of von Willebrand factor during acute systemic inflammation
2005
·
Rosemarie Reiter
, Katalin Varadi
, et al.
·
Thrombosis and Haemostasis
·
130
Factor V Enhances the Cofactor Function of Protein S in the APC-Mediated Inactivation of Factor VIII: Influence of the Factor VR506Q Mutation
1996
·
K Váradi
, J Rosing
, et al.
·
Thrombosis and Haemostasis
·
127
Factor VIII Inhibitor-Bypassing Agents Act by Inducing Thrombin Generation and Can Be Monitored by a Thrombin Generation Assay
2003
·
P.L. Turecek
, K. Váradi
, et al.
·
Pathophysiology of Haemostasis and Thrombosis
·
122
Changes in von Willebrand factor–cleaving protease (ADAMTS13) activity after infusion of desmopressin
2003
·
Rosemarie A. Reiter
, Paul Knöbl
, et al.
·
Blood
·
120
BAX 855, a PEGylated rFVIII product with prolonged half-life. Development, functional and structural characterisation.
2012
·
P L Turecek
, M J Bossard
, et al.
·
PubMed
·
107
Measurement of von Willebrand factor-cleaving protease (ADAMTS-13) activity in plasma: a multicenter comparison of different assay methods
2003
·
J.-D. Studt
, M. Böhm
, et al.
·
Journal of Thrombosis and Haemostasis
·
98
PDF
Circulating nucleosomes and severity of illness in children suffering from meningococcal sepsis treated with protein C
2012
·
Sacha Zeerleder
, Femke Stephan
, et al.
·
Critical Care Medicine
·
85
Development of a plasma- and albumin -free recombinant von Willebrand factor
2009
·
P. L. Turecek
, A. Mitterer
, et al.
·
Hämostaseologie
·
67
Factor Xa and Prothrombin: Mechanism of Action of FEIBA
1999
·
Peter L. Turecek
, Katalin Varadi
, et al.
·
Vox Sanguinis
·
67
PDF
Second international collaborative study evaluating performance characteristics of methods measuring the von Willebrand factor cleaving protease (ADAMTS‐13)
2008
·
A. TRIPODI
, F. PEYVANDI
, et al.
·
Journal of Thrombosis and Haemostasis
·
63
PDF
Thrombin generation assay and other universal tests for monitoring haemophilia therapy
2004
·
K. Váradi
, P. L. Turecek
, et al.
·
Haemophilia
·
62
Structure and Function of a Recombinant von Willebrand Factor Drug Candidate
2010
·
Peter Turecek
, Gerald Schrenk
, et al.
·
Seminars in Thrombosis and Hemostasis
·
59
Optimization of conditions for the catalytic effect of the factor IXa - Factor VIII complex
1979
·
Susan Elõdi
, Katalin Váradi
·
Thrombosis Research
·
58
BAX 855, a PEGylated rFVIII product with prolonged half-life: Development, functional and structural characterisation
2012
·
M. J. Bossard
, M. Graninger
, et al.
·
Hämostaseologie
·
52
Pro‐ and anticoagulant factors facilitate thrombin generation and balance the haemostatic response to FEIBA® in prophylactic therapy
2016
·
K. Varadi
, S. Tangada
, et al.
·
Haemophilia
·
44
PDF
Influence of Factor V and Factor Va on APC-Induced Cleavage of Human Factor VIII
1995
·
Katalin Váradi
, Jan Rosing
, et al.
·
Thrombosis and Haemostasis
·
34
A chromogenic assay for activated protein C resistance
1995
·
K. VARADI
, B. MORITZ
, et al.
·
British Journal of Haematology
·
27
Inactivation of Human Factor VIII by Granulocyte Proteases
1980
·
Katalin Váradi
, Katalin Marossy
, et al.
·
Thrombosis and Haemostasis
·
26
Activation of clotting factors in prothrombin complex concentrates as demonstrated by clotting assays for factors IXa and Xa
1978
·
Susan Elõdi
, Katalin Váradi
·
Thrombosis Research
·
26
Inverse correlation of free and immune complex‐sequestered anti‐ADAMTS13 antibodies in a patient with acquired thrombotic thrombocytopenic purpura
2011
·
S. FERRARI
, P. KNÖBL
, et al.
·
Journal of Thrombosis and Haemostasis
·
25
PDF
Evidence for Extracellular Processing of Pro-von Willebrand Factor After Infusion in Animals With and Without Severe von Willebrand Disease
1999
·
P.L. Turecek
, L. Pichler
, et al.
·
Blood
·
25
Show more works
View as search
Works count:
78
Citation count:
2,561
H-index:
25
I10-index:
39
Year
Topic
Type